Outcome following staphylococcal peritonitis.
OBJECTIVE
Staphylococcus spp predominate as the causative pathogen of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis.This study evaluated the difference in morbidity and mortality between peritonitis caused by S. aureus and coagulase-negative staphylococci (CoNS).


METHODS
Prospective observational study.


METHODS
A single regional dialysis unit in a teaching hospital.


METHODS
Thirty-seven patients had S. aureus peritonitis and 65 patients had CoNS peritonitis between July 1990 and November 1995.


METHODS
Using the first recorded episode of peritonitis, survival analysis was performed for time to (1) death, (2) removal of peritoneal dialysis catheter, and (3) change to hemodialysis. Abdominal complications were recorded for the first and subsequent episodes.


RESULTS
No difference in time to death was demonstrated for the two groups (p = 0.79), although two deaths that occurred during therapy for peritonitis were attributable to S. aureus infection. In addition, 5 patients developed serious abdominal complications related to an episode of S. aureus peritonitis. Patients with S. aureus peritonitis had a shorter time to both peritoneal dialysis catheter removal (p = 0.004) and change to hemodialysis (p = 0.014). The change in mode of dialysis was independent of catheter loss.


CONCLUSIONS
This study highlights the serious nature of S. aureus peritonitis and confirms the need for effective preventive measures against infection by this pathogen.
Peacock
S J
SJ
Nuffield Department of Pathology and Bacteriology, The Oxford Radcliffe Hospital NHS Trust, Oxford, United Kingdom. sharon.peacock@ndp.ac.ox.uk
Howe
P A
PA
Day
N P
NP
Crook
D W
DW
Winearls
C G
CG
Berendt
A R
AR
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002404:Catheterization; D003030:Coagulase; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality; D011446:Prospective Studies; D013203:Staphylococcal Infections; D013210:Staphylococcus / Q000201:enzymology; D015996:Survival Rate; D016896:Treatment Outcome
D003030:Coagulase